We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

61 hedge funds and large institutions have $374M invested in Fulcrum Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

86% more capital invested

Capital invested by funds: $201M → $374M (+$173M)

30% more funds holding

Funds holding: 4761 (+14)

2.52% more ownership

Funds ownership: 72.05%74.58% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
61
Holders Change
+14
Holders Change %
+29.79%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
18
Increased
21
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$751K +$187K +11,902 +41%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$583K -$21.9K -1,389 -4%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$581K +$500K +31,744 New
Charles Schwab
29
Charles Schwab
California
$546K +$47.7K +3,029 +11%
CC
30
Cannell & Co
New York
$410K
CTB
31
Country Trust Bank
Illinois
$402K -$315K -20,000 -48%
State of Wisconsin Investment Board
32
State of Wisconsin Investment Board
Wisconsin
$357K
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$351K
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$342K +$118K +7,502 +67%
Bank of America
35
Bank of America
North Carolina
$298K +$12.9K +818 +5%
Los Angeles Capital Management
36
Los Angeles Capital Management
California
$285K +$77.9K +4,950 +47%
BM
37
Brandywine Managers
Delaware
$281K
Wells Fargo
38
Wells Fargo
California
$279K +$97.2K +6,176 +68%
AllianceBernstein
39
AllianceBernstein
Tennessee
$274K +$236K +15,000 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$233K +$200K +12,725 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$224K +$102K +6,500 +113%
HA
42
HC Advisors
Georgia
$216K +$186K +11,800 New
AIG
43
American International Group
New York
$140K +$2.66K +169 +2%
SG Americas Securities
44
SG Americas Securities
New York
$126K +$108K +6,862 New
Deutsche Bank
45
Deutsche Bank
Germany
$117K +$27.9K +1,774 +38%
MIM
46
MetLife Investment Management
New Jersey
$115K +$98.7K +6,267 New
PCM
47
Prelude Capital Management
New York
$111K +$95.6K +6,073 New
JP Morgan Chase
48
JP Morgan Chase
New York
$87K -$259K -16,426 -78%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$79.2K +$52.2K +3,313 +326%
UBS Group
50
UBS Group
Switzerland
$79K -$59.4K -3,773 -47%

FULC Hedge Fund Activity: Q2 2020 in Review

61 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q2 2020, worth a combined $374M — up 86% from $201M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new FULC positions and 4 closed out — a net gain of 14 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.9M. The largest seller was Millennium Management, cutting an estimated $2.17M.

  • 61 institutional investors held Fulcrum Therapeutics (FULC) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $374M of Fulcrum Therapeutics stock for Q2 2020, up 86% quarter-over-quarter.
  • 18 funds opened new Fulcrum Therapeutics positions in Q2 2020 and 4 closed out, a net change of +14 holders.
  • The largest Fulcrum Therapeutics buyer in Q2 2020 was EcoR1 Capital, an estimated $13.9M added.
  • The largest Fulcrum Therapeutics seller in Q2 2020 was Millennium Management, an estimated $2.17M sold.

Based on aggregated 13F filings for Q2 2020.